News
Wingstop (WING) stock has fallen 53 % over the past year, yet a DCF analysis values the shares at roughly $171, implying a 10.4 % upside from the current price of $153.29. The valuation debate hinges on the company’s unit economics and the risk of same‑store sales decline and cannibalization as it expands its digital platform, MyWingstop, and loyal...
14/07/2026 | Wingstop Inc.
The impact of the merger and cost‑cutting measures remains to be seen, but COUR stock appears oversold. With relatively muted growth being a concern, the company's revenue guidance for FY26 is $810 million. Coursera has a widely addressable market through its online learning platform, serving approximately 197 million learners from over 230 countri...
14/07/2026 | Coursera, Inc.
Coursera's stock (COUR) has experienced a decline of 32.2% over the last 52 weeks, with negative sentiments surrounding growth concerns. Despite this, the company's merger with Udemy in June 2025 is expected to drive cost optimization and potential growth acceleration. Following the merger, Coursera announced job cuts for an unspecified number of e...
14/07/2026 | Coursera, Inc.
The completion of the Udemy merger positions Coursera to benefit from the latter's enterprise assets, which could drive subscription growth. With potential benefits from the merger, COUR stock seems attractive. Analysts have a consensus “Moderate Buy” rating for the stock, with a mean price target of $7.91 representing an upside potential of 39% fr...
14/07/2026 | Coursera, Inc.
MBX Biosciences (MBX) on Monday named executive chairman Steve Hoerter as chairman and chief executive officer, succeeding co‑founder Kent Hawryluk, who will step down as president, chief executive officer and a member of board. The company said it also appointed John Smither, currently interim CFO, as chief financial officer. The executive changes...
14/07/2026 | MBX Biosciences, Inc.
The Company remains committed to its mission of improving lives for patients living with endocrine and metabolic diseases. The leadership transitions do not appear to have altered MBX's strategic priorities or its commitment to delivering value for shareholders and patients.
14/07/2026 | MBX Biosciences, Inc.
The appointment of John Smither as Chief Financial Officer has also been announced, with Mr. Smither continuing to lead the Company’s finance organization and support operational and strategic priorities. The leadership changes are effective immediately, and additional information will be disclosed in a Current Report on Form 8‑K filed with the U.S...
14/07/2026 | MBX Biosciences, Inc.
The leadership of MBX Biosciences has undergone significant changes. Steve Hoerter, current Executive Chairman, has been appointed as the new Chairman and Chief Executive Officer, replacing Kent Hawryluk who will step down from his positions. Mr. Hoerter brings extensive experience in building and scaling commercial-stage biotechnology companies, h...
14/07/2026 | MBX Biosciences, Inc.
As a leading global player in construction consultancy, Arcadis operates in over 30 countries, with reported gross revenues of €4.9 billion for 2025. The company is committed to accelerating a planet‑positive future by making sustainable project choices, combining digital and human innovation, and embracing future‑focused skills across various sect...
14/07/2026 | Arcadis NV
Strategically, Renault is expanding vehicle R&D and software development in China, a move aimed at capturing the region’s electric‑vehicle and digital‑mobility momentum. New senior leaders overseeing legal, compliance, partnerships, and digital transformation will shape how the company allocates capital, structures joint ventures, and navigates sup...
13/07/2026 | Renault S.A.